Cartilage tissue engineering using bone marrow-derived mesenchymal stem cells (BM-MSCs) is a growing technology for the repair of joint defects. Culturing BMMSCs to over confluence has historically been avoided due to perceived risk to cell viability, growth inhibition and differentiation potential. Here we show that a simple change in culture practice, based on mimicking the condensation phase during embryonic cartilage development, results in biochemically and histologically superior cartilage tissue engineered constructs. Whole transcriptome analysis of the condensing cells revealed a phenotype associated with early commitment to chondrogenic precursors. This simple adjustment to the common stem cell culture technique would impact the quality of all cartilage tissue engineering modalities utilising these cells.
INTRODUCTION
Cartilage tissue engineering strategies have sought a cell population capable of enhanced chondrogenesis that could be reliably used in regenerative medicine strategies (1) . Mesenchymal stem cells (MSCs) taken from the bone marrow are a very commonly used cell type for such strategies. These cells however suffer from heterogeneity; a lack of consistent culture methods leads to variable outcomes in cartilage repair approaches (2, 3) . Many strategies have been explored to improve the consistency of MSC-based cartilage regeneration including clonal expansion based on cell surface markers (e.g. STRO-1 (4), CD271
(5) and ROR2 (6) ). Whilst such approaches have showed promise they remain inefficient and expensive.
Scaling up tissue engineering strategies for regenerative medicine applications will require a large number of cells invariably taken through multiple doublings.
Historically, MSC cell culture methodologies have avoided growing MSCs to over confluence since it was hypothesised it can lead to decreased cellular viability and differentiation potential (7, 8) . Increased confluence or cell density is found during embryonic chondrogenesis when previously dispersed mesenchymal cells condense to differentiate into chondrocytes -the earliest sign of skeletal development through endochondral ossification (9, 10) . In vitro culture of BMMSCs to over confluence can recapitulate cell condensation behaviour in vivo prior to chondrogenesis.
Here we demonstrate for the first time that BM-MSCs cultured to over confluence not only maintain their cellular viability but are able to produce three-dimensional cartilage constructs of superior quality than cells cultured by traditional methods. This simple methodological change in culture will facilitate enhanced in vitro cartilage production using BM-MSCs for a wide range of cartilage cell-based therapies.
RESULTS & DISCUSSION

BASIC CHARACTERISATION OF OVER CONFLUENT MSC'S.
The growth kinetics and multipotency of over confluent BM-MSCs was assessed at multiple time points and over a number of passages. This was performed in order to ascertain whether BM-MSCs grown to over confluence maintain their 'stemness'. BM-MSCs from 5 individual donors were plated at a known cell density (2000 cells/cm 2 ) in multiple culture flasks and harvested at set time points to determine the cell density, cellular viability and population doubling time. Cell density analysis demonstrated a gradual increase in confluence over 24 days post plating in passage 2 cells (Fig. 1A) . Visual confirmation of confluence was attained in all populations by 10 days (Supplementary Fig 1) .
The population doubling time -a measurement of cellular proliferationincreased as cell density increases (Fig 1B) . Flow cytometry analysis of harvested cells -utilising propidium iodide (PI) as a viability marker -revealed viability in excess of 90% at all time points (Fig. 1C) . Further evidence of maintained cellular viability in over confluent cells was demonstrated by the continued proliferation of over confluent cells following re-plating. Over confluent cells re-plated at a low cell density demonstrated an initial lag in proliferation (Fig. 1A , D, G). Following 4 days in culture, the population doubling time decreased, correlating with an increase in cell density and confluence ( Fig   1D&E) . Cell viability was less than the previous passage for the first few days returning to pre-plating levels after 3 days in culture. Cellular viability remained in excess of 85% in all populations at all time points in passage 3 ( Fig 1E) .
Passage 3 cells cultured for 24 days were again re-plated to assess proliferation and viability. These cells were able to proliferate at a similar rate to cells from previous passages and maintain viability in excess of 90% at most time points (Fig 1H&I) . Increase in cell density followed a similar pattern to those cells in passage 3 with a gradual increase to 14 days in culture followed by a slight decrease in cell density at 24 days (Fig 1G) . The growth curve of over confluent cells is linear and extended at passage 2 compared to replated over-confluent cells at later passages.
In order to assess the multipotency of over confluent BM-MSCs, 6 individual cell lines were permitted to reach over confluency and (after 24 days in culture)
were stimulated to differentiate into adipogenic and osteogenic lines with the appropriate growth factors. The resulting monolayer cultures along with the corresponding undifferentiated controls were stained and photographed using bright field microscopy ( Supplementary Fig 2) . All cell lines underwent adipogenic and osteogenic differentiation confirming the maintenance of multipotency in over confluent cells. The adipogenic and osteogenic potential of these cell lines at low confluence (8 days in culture) was confirmed and appeared similar to over confluent cultures ( Supplementary Fig 2) .
In summary, confluence is defined as a visual measurement of the fraction of growth area covered by cells while cell density provides a quantification of proliferation, albeit as a result of detachment or destructive assays (12) . Cell culture methodology has historically avoided cellular over confluence as it is believed that over confluence negatively affects cell viability and differentiation (7, 8) . This study demonstrated that cell viability in excess of 90% was maintained in each cell line cultured up to 24 days proving that cellular viability is not negatively affected by over confluence as was once assumed. Furthermore, trilineage potential was maintained in these cells demonstrating the ability of over confluent BM-MSCs to maintain their stem cell properties after confluence is reached. To our knowledge this is the first study to demonstrate that BM-MSCs cultured to over confluence maintain both cellular viability and trilineage potential.
OVER CONFLUENT BM-MSCS GENERATE IMPROVED TISSUE-ENGINEERED CARTILAGE.
We hypothesised that over confluent MSCs could recapitulate early embryonic events associated with active chondrogenesis and therefore an improved tissue engineered cartilage. To test this hypothesis, three-dimensional cartilage tissue engineering was performed using BM-MSCs from 10 individual cell lines harvested at low confluence (5 days) and over confluence (24 days) and stimulated to undergo chondrogenesis in the presence of TGF-b3. These constructs were then analysed to determine the quality of the cartilage produced using histology, biochemical assays and RT-qPCR gene expression quantification.
All 10 cell lines produced constructs resembling cartilage at a macroscopic level; no macroscopic difference was observed between the paired constructs from low and over confluent cells (Fig 2A and Supplementary Fig 3) . This observation was confirmed by the negligible difference in the wet weight of the cartilage scaffolds following harvest and the similar dry weights of the ECM in the lyophilised constructs (Supplementary Fig 3B) . The constructs generated using over confluent cells produced significantly superior cartilage ECM. Histological analysis of the constructs revealed an ECM that stained extensively for proteoglycan and type II collagen and weakly for type I collagen in the over confluent constructs (Fig 2B, C, D & E) . Extensive quantitative analysis of the engineered cartilage ECM was performed to determine the biochemical composition of the cartilage constructs utilising well-validated assays (14) .
Paired analysis comparing low confluent and over confluent constructs demonstrated a significantly increased type II collagen to type I collagen ratio (TII/TI ratio) and proteoglycan content in over confluent constructs (Fig 2H) . A 2-fold increase in the TII/TI ratio was seen in the over confluent constructs while a 1.3 fold increase in proteoglycan content was seen over the low confluent constructs. The improved collagen ratio resulted from a significantly increased type II collagen content and a decreased type I collagen content in over confluent constructs (Fig 2I) . Type X collagen (marker of hypertrophic cartilage) gene expression analysis using RT-qPCR demonstrated a significant 3-fold reduction in expression in constructs generated from over confluent BM-MSCs (Fig 2F) .
It is clear therefore that cartilage tissue engineering utilising over confluent BMBMCs produced significantly superior cartilage constructs than those cells harvested at low confluence.
THE CHONDROGENIC MARKER ROR2 IS DEPENDANT ON CELL
DENSITY.
The Wnt5a receptor ROR2 has been shown to be predictive of enhanced chondrogenesis in BM-MSCs. Flow cytometry analysis of ROR2 expression in BMMSCs revealed a direct relationship between culture confluence and ROR2 expression (6) . To prove this association 6 individual cell lines were plated at a low cell density (2000 cells/cm 2 ) and harvested at serial time points until 24 days in culture for ROR2 analysis using flow cytometry. The gating strategy for ROR2 analysis of these samples is detailed in Supplementary Fig 4A. There is a clear relationship between cell density -as measured by time in culture -and whole population (WP) ROR2 expression ( Fig 3A) . Cells cultured for 24 days were re-plated (Passage 3) at the initial cell density to assess the effect of replating on WP ROR2 expression. Re-plating resulted in an initial decrease in WP ROR2 expression, which was followed by an increase in expression with further days in culture (Fig 3B) . This pattern was repeated following further re-plating of cells (Passage 4) cultured for 24 days (Fig 3C) Figure 5A ). Hierarchical analysis was performed after filtering for significance (2-fold change and FDR of 0.05) and displayed as a heat map (see Figure 4A ). This demonstrates that genes were predominantly downregulated in the over confluent cell lines when compared to the same cell lines at low confluence.
Functional analysis revealed down regulation of genes associated with the cell cycle, cellular senescence and regulation of actin cytoskeleton (see Figure 4B ). Down-regulation of cell cycle genes points to a cell line slowing proliferation due to the attainment of confluence and limited space to proliferate. This is further corroborated by a significant downregulation of the proliferative growth factor FGF-2 (see Fig 4B) . These cells appear to be resilient to cellular stressors such as oxidative stress and DNA damage as demonstrated by the down-regulation of the cellular senescence pathways (16) . A slow of proliferation following the formation of condensations is said to occur as these cells adapt to a high cell density environment before differentiation begins (17) . Slowing of proliferation as confluence is achieved is reflected in vitro in these cells as set out above (see Figure 1B ). Murine embryonic stem cells have been shown to differentiate into chondrocytes by the addition of an actin cytoskeleton inhibitor (18) .
Furthermore, overexpression of actin binding protein results in upregulation of hypertrophic markers (19). Down-regulation of actin cytoskeleton in over confluent cells may be an indicator of maintenance of a non-hypetrophic phenotype in these MSCs which is in line with our qPCR data (Fig 2F) .
Of the genes that were up-regulated in the over confluent cell lines, a few provided possible mechanistic explanations for the improved chondrogenic potential seen in over confluent cell lines. Members of the TGF group of growth factors are known to be essential to the chondrogenic potential of MSCs both in vitro and in vivo (20) (21) (22) . TGF-b2 and TGF-b3 are significantly up-regulated in over confluent cell lines (see Figure 4C ). Evidence in favour of over confluence cells mimicking condensation formation is provided when considering that 
MATERIALS & METHODS
COLLECTION OF BONE MARROW
Three-Dimensional Cartilage Tissue Engineering
Ethylene oxide was used to sterilise the PGA scaffolds (Anderson Caledonia, Bellshill, Scotland). In order to remove contaminants, the scaffolds were immersed in absolute ethanol for 5 minutes and washed three times in PBS. The scaffolds were coated with 10 µg/mL of fibronectin (Sigma) and allowed to dry overnight in a sterile laminar flow cabinet. To prevent the cells from adhering to the culture plate, the required wells were coated with 500 µL 1% agarose. The dried fibronectin-coated scaffolds were added to the agarose wells and rehydrated with expansion medium. The MSCs were trypsinised, counted and centrifuged. A total of 5x10 5 cells per scaffold were re-suspended in 30 µL of expansion medium. The expansion medium was removed from the scaffolds immediately prior to seeding. The cells were carefully seeded onto the scaffolds taking care to equally distribute the cell suspension. The scaffolds were placed in a humidified incubator at 37°C containing 5% CO2 overnight to allow the cells to adhere to the scaffold. The scaffolds were then turned and incubated for a further 2 hours to allow even cell distribution and adhesion; the scaffolds were then supplied with ITS basal medium supplemented with 10 ng/mL rhTGFß3 (R&D Systems), 100 nM dexamethasone, 80 µM ascorbic acid 2-phosphate (both Sigma) and incubated on a rotating platform at 50 rpm in a humidified incubator with 5% CO2 at 37°C. Media was renewed every 3 days for a total of 35 days; insulin at 10 µg/mL concentration was added to the basal medium supplement from day 7. After a total of 35 days in culture the scaffolds were harvested, photographed and placed in pre-weighed tubes. The constructs were stored at -20°C until freeze-drying.
The tissue engineered cartilage constructs were used to analyse the matrix composition in relation to the glycosaminoglycan (GAG), collagen I and collagen II content of these constructs.
Prior to digestion the constructs were lyophilised in a freeze dryer (Savant Modulyo, Thermo Scientific) for 24 hours. The freeze-dried sample were then weighed and subtracted from the tube weight to determine the dry weight of the constructs. The dried constructs were digested by adding trypsin in two steps.
The initial trypsin aliquot was added together with three proteases to prevent non-specific protease activity in the constructs and incubated at 37°C on a rotating platform (100 rpm) for 12 hours. The second aliquot of trypsin was added to the mixture and incubated at 65°C for a further 3 hours; the mixture was subsequently boiled for 15 minutes to inhibit the trypsin activity. The volume of trypsin used was determined by the dry weight of the constructs -50 µL per 0.5 mg. The resultant mixture was then centrifuged at 13 000 rpm for 5 minutes and the supernatant aspirated and stored at 4°C for analysis. The remaining undigested material was further freeze dried and weighed to determine the final dry weight of the digested ECM:
Dry weight of digested ECM = Dry weight of freeze-dried scaffold/ECM construct -Dry weight of undigested material.
Gene analysis of tissue engineered cartilage
The cartilage tissue constructs for gene analysis were stored until processing at -80°C. The construct was processed using the Total RNA Purification Kit (Norgen Biotek). The constructs were prepared for processing by cutting each sample into 2mm x 2mm pieces and immediately immersed in the lysis buffer. The sample was crushed using a small pestle and repeatedly passed through a 21 gauge needle until the sample passed through easily. The sample was then passed through a 25 gauge needle to shear the genomic DNA. Absolute ethanol was then added to the lysate and vortexed to ensure adequate mixing.
The lysate was then transferred into a spin-column and centrifuged at room temperature at 14 000 rpm for 2 minutes. The remaining RNA in the spincolumn -after discarding the flow-through -was washed three times and centrifuged to leave the RNA collected in the resin thoroughly dry. The bound RNA was then eluted and quantified to assess concentration and purity using a NanoDrop spectrophotometer (Thermo Scientific).
Purified RNA was transcribed into cDNA using the PrimeScript Reagent Kit The expression of the hypertrophic chondrogenic marker gene -collagen Xwas measured using RT-qPCR with TaqMan ® as the fluorescence reporter. A one-step RT-qPCR reaction will be used to amplify the cDNA using the QuantStudio Real-Time PCR System (ThermoFisher Scientific, Waltham, USA).
Each sample will be processed in triplicate with beta actin used as a control gene.
Comparitive quantification of the selected chondrogenic genes was calculated using the ΔΔCTt method.
Biochemical analysis of cartilage constructs
The proteoglycan content of each scaffold was measured using a colourmetric assay to detect sulphated GAG (25) . A set of 11 standards was used for this assay and prepared by diluting chondroitin sulphate in dH2O in 5 µg/mL increments from 0 µg/mL to 50 µg/mL. A 96-well, round-bottomed microplate (Corning) was used and set up as follows: a row of blank (B) negative control wells containing 20 µL of dH2O, the 11 standards (S1-11) were added in duplicate with 20 µL being added to each well and finally 20 µL of each sample (U) was transferred to the plate in duplicate. A total of 250 µL of BMB was added to each well and the optical density of the samples was read using a Glomax plate reader set at 525 nm (Promega, Madison, USA). The amount of GAG in each sample is expressed as a percentage of the dry weight of the digested ECM.
The collagen content of tissue engineered cartilage was measured by an inhibition ELISA assay using a primary antibody against a peptide (AH23) specific to collagen type I (26) . A primary antibody (AH23-1319) was used to bind type I collagen present in the digested ECM; the remaining antibody not bound to the sample collagen was measured by allowing the remaining antibody to bind to AH23 pre-coated on a separate plate. A secondary antibody conjugated to alkaline phosphatase was added to determine the amount of antibody not bound to the initial sample. The collagen content of the sample ECM can then be calculated and expressed as a percentage of the dry-weight of the digested ECM. The collagen type II content of the tissue engineered cartilage will be measured using an inhibition ELISA by using a primary antibody (COL2-3/4) against a peptide specific to collagen type II (CB11B) (27) . 
Histological analysis of tissue engineered cartilage
The tissue engineered cartilage constructs were immersed in OCT embedding matrix (BDH Chemicals, Poole, UK) and suspended over liquid nitrogen until the OCT solidified thus embedding the constructs in OCT. These were then cut into 7 µm sections using a cryostat before being transferred to polysine microscope slides. The sections were permitted to dry at room temperature for 30 minutes and then fixed in 4% (w/v) paraformaldehyde (Sigma) at 4°C for 30 minutes.
The sections were then washed in PBS and stored until staining.
Prepared sections were rehydrated in dH2O for approximately 5 minutes.
Haematoxylin (Vector Laboratories, Peterborough, UK) was initially used to stain the sections. After approximately 2 minutes any access haematoxylin stain was removed with dH2O before 1% eosin (Vector Laboratories) was added. After 2 minutes the sections were rinsed in 70% then 90% and then 100% ethanol before being cleared in xylene for 5 minutes. The sections were then mounted in DPX mounting medium and covered with a cover slip.
The sections were rehydrated as above and stained with 0.02% (w/v) fast green (Sigma Aldrich) for 4 minutes and then rinsed in 1% acetic acid. The 0.1% (w/v) Safranin-O stain (Sigma Aldrich) was then added to the sections for 6 minutes.
The sections were then rinsed in 70%, 90% and 100% ethanol before being cleared in xylene for 5 minutes. The sections were then mounted in DPX mounting medium and covered with a cover slip.
The prepared sections were subjected to enzymatic retrieval by initially treating with a 0.1% (w/v) pronase (Sigma Aldrich) solution before being incubated at room temperature in a humidified chamber. The sections were then washed with PBS and then treated with 2% (w/v) hyaluronidase (Sigma Aldrich) at 37°C for twice in PBS for 2 minutes each and treated with 3% hydrogen peroxidase at room temperature for 10 minutes and washed in PBS.
Prior to staining for collagen type II the sections were blocked with Novolink protein (Leica Biosystems, Weltzlar, Germany) for 5 minutes at room temperature. After a rinse in PBS the primary collagen type II antibody -diluted to 1 in 4000 in Tris buffered saline (TBS) solution (20 mM Tris and 150 mM NACl) and 1% goat serum -was incubated overnight at 4°C with an appropriate isotype control. The primary antibody to collagen type II used was II-II6B3 (DSHB, deposited by Linsenmayer, T.F.) and the isotype control was a mouse IgG1 istotype (2b Scientific, UK). The antibodies were washed in TBS three times for three minutes at a time before the Novolink post primary block (Leica biosystems) was applied for 30 minutes at room temperature. After another three washes in TBS the Novolink polymer (Leica biosystmes) was applied for another 30 minutes at room temperature. The sections were then treated with DAB (3,3'-Diaminobenzidine) and incubated at room temperature for 3 minutes.
The DAB was removed with dH2O and haematoxylin stain was applied for 3 minutes before a final wash in preparation for dehydration. The sections were dehydrated in 70%, 90% and 100% ethanol for 5 minutes each and cleared in xylene and mounted using DPX and covered with a cover slip.
The sections were initially subjected to enzymatic retrieval. Prior to staining the sections were blocked with Novolink protein (Leica Biosystems) for 5 minutes at room temperature. The primary collagen type I antibody (ab23446, Abcam, Cambridge, UK) -diluted 1 in 100 in TBS with 1 % goat serum -was incubated overnight at 4°C with the appropriate isotype control (ab170190, Abcam).
Following incubation, the sections were washed three times in TBS. The final preparation of the slides is as was performed in the preparation of the collagen type II stained slides as above.
ROR2 IMMUNOPHENOTYPING BY FLOW CYTOMETRY
Analysis of ROR2 in cultured adult BM-MSCs
Bone marrow derived MSCs were harvested, counted, centrifuged and washed twice in flow buffer (0.5% w/v BSA in PBS (both from Sigma)). For each sample 200 000 cells was transferred into sterile polystyrene test tubes (BD Bioscience) and stained with the appropriate primary antibody (see Table 1 ). The samples were then incubated at -4°C in the dark for 30 minutes and then washed twice with flow buffer. The secondary antibody was introduced and again allowed to incubate at -4°C in the dark for 30 minutes. After removing the unbound secondary antibodies with flow buffer, propidium iodide (Sigma) was used to identify dead cells: 2.5 µg/mL was added immediately prior to analysis. The cells were processed using the MACSQuant Analyser 10 flow cytometer (Mitenyi) and the data analysed with FloJo software (Treestar). 
RNA-SEQ ANALYSIS OF LOW AND OVER CONFLUENT BM-MSCS
Adult BM-MSCs from 3 individual cell lines were thawed and plated in proliferation media. Once 80% confluency was reached the cells were harvested and plated at a cell density of 2000 cells/cm 3 and permitted to proliferate for 5 days (low confluence) and 24 days (over confluence) before being harvested for RNA extraction.
The construct was processed using the Ambion Purelink RNA Purification Kit (ThermoFisher Scientific). The sample was then passed through a 21 gauge needle to shear the genomic DNA. Absolute ethanol was then added to the lysate and vortexed to ensure adequate mixing. The lysate was then transferred into a spin-column and centrifuged at room temperature at 14 000 rpm for 2 minutes.
The remaining RNA in the spin-column -after discarding the flow-through -was washed three times and centrifuged to leave the RNA collected in the resin thoroughly dry. The bound RNA was then eluted and quantified to assess concentration and purity using a NanoDrop spectrophotometer (Thermo Scientific). The RNA was then stored in lysis buffer (with B-MB) in RNA-free centrifuge tubes and stored at -80°C and shipped to Novogene (Beijing, China)
for medical transcriptome analysis. The data was analysed using Partek ® Flow ® software. 
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